Shifeng Kan

637 total citations
26 papers, 390 citations indexed

About

Shifeng Kan is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Shifeng Kan has authored 26 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Shifeng Kan's work include Phytoestrogen effects and research (3 papers), Natural product bioactivities and synthesis (2 papers) and Cerebral Palsy and Movement Disorders (2 papers). Shifeng Kan is often cited by papers focused on Phytoestrogen effects and research (3 papers), Natural product bioactivities and synthesis (2 papers) and Cerebral Palsy and Movement Disorders (2 papers). Shifeng Kan collaborates with scholars based in China, Singapore and United Kingdom. Shifeng Kan's co-authors include Yun Bai, Cheng‐Bao Zhu, Hongkui Deng, Shixin Zhou, Yuting Wang, Jun Xu, John P. Cooke, Zhen Wu, Jinhua Wen and Xin Lü and has published in prestigious journals such as Journal of Biological Chemistry, British Journal of Cancer and Experimental Cell Research.

In The Last Decade

Shifeng Kan

24 papers receiving 384 citations

Peers

Shifeng Kan
Yongzhong Luo China
Anna Paczulla Germany
Yue Teng China
Chengcheng Liao China
Qi Niu China
Michael Cangkrama Switzerland
Chengyu Lv China
Xiangyu Zhai China
Huijuan Zhou China
Yongzhong Luo China
Shifeng Kan
Citations per year, relative to Shifeng Kan Shifeng Kan (= 1×) peers Yongzhong Luo

Countries citing papers authored by Shifeng Kan

Since Specialization
Citations

This map shows the geographic impact of Shifeng Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifeng Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifeng Kan more than expected).

Fields of papers citing papers by Shifeng Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifeng Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifeng Kan. The network helps show where Shifeng Kan may publish in the future.

Co-authorship network of co-authors of Shifeng Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Shifeng Kan. A scholar is included among the top collaborators of Shifeng Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifeng Kan. Shifeng Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dafeng, et al.. (2025). CMAS corrosion behavior of plasma-sprayed yttria-stabilized zirconia thermal barrier coatings glazed by excimer laser. Ceramics International. 51(27). 52282–52294.
2.
Wang, Dafeng, Shaofei Liu, Longjun He, et al.. (2025). In-situ preparation of CNTs/WC-CoCr powder and their HVAF coatings: microstructure and mechanical properties. International Journal of Refractory Metals and Hard Materials. 134. 107496–107496.
3.
Sun, Li, et al.. (2023). Fatty Acid Binding Protein 5 (FABP5) Promotes Aggressiveness of Gastric Cancer Through Modulation of Tumor Immunity. Journal of the Korean Gastric Cancer Association. 23(2). 340–340. 5 indexed citations
4.
Yan, Sheng, Bin Peng, Shifeng Kan, et al.. (2023). Polo-like kinase 1 (PLK1) O-GlcNAcylation is essential for dividing mammalian cells and inhibits uterine carcinoma. Journal of Biological Chemistry. 299(2). 102887–102887. 12 indexed citations
5.
Wu, Jiyong, Dongbo Wang, Jing Nie, et al.. (2022). Design and Synthesis of an Hsp90 and HDAC Dual Inhibitor as AntitumorAgent. Letters in Drug Design & Discovery. 20(6). 619–627. 1 indexed citations
6.
7.
Liu, Xiuxiu, et al.. (2021). MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165/Flt-1 signaling pathway in head and neck squamous cell carcinoma. International Immunopharmacology. 96. 107776–107776. 7 indexed citations
8.
Liu, Xiuxiu, Zhancheng Zhang, Shifeng Kan, et al.. (2021). PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the OCT4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma. International Journal of Oncology. 59(1). 8 indexed citations
9.
10.
Yang, Junsheng, et al.. (2020). Integrated Analysis of Gene Expression and Metabolite Data Reveals Candidate Molecular Markers in Colorectal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 37(10). 907–916. 9 indexed citations
11.
Kan, Shifeng, et al.. (2019). DNA methylation profiling identifies potentially significant epigenetically‑regulated genes in glioblastoma multiforme. Oncology Letters. 18(2). 1679–1688. 8 indexed citations
12.
Chai, Song‐Hai, Shifeng Kan, Ran Sun, et al.. (2018). Fabricating polydopamine-coated MoSe<sub>2</sub>-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy. International Journal of Nanomedicine. Volume 13. 7607–7621. 27 indexed citations
13.
Shen, Xue, Shifeng Kan, Zhen Liu, et al.. (2017). EVA1A inhibits GBM cell proliferation by inducing autophagy and apoptosis. Experimental Cell Research. 352(1). 130–138. 31 indexed citations
14.
Wu, Zhen, Jing Wu, Ping Fang, & Shifeng Kan. (2017). Puerarin increases the chemosensitivity of hepatocellular carcinoma cells. Oncology Letters. 14(3). 3006–3010. 7 indexed citations
15.
Shen, Xiaomeng, Shifeng Kan, Jia Hu, et al.. (2016). EMC6/TMEM93 suppresses glioblastoma proliferation by modulating autophagy. Cell Death and Disease. 7(1). e2043–e2043. 40 indexed citations
16.
Song, Min Kyung, et al.. (2015). Targeting Human Poly(ADP‐Ribose) Polymerase‐1 with Natural Medicines and Its Potential Applications in Ovarian Cancer Therapeutics. Archiv der Pharmazie. 348(11). 817–823. 6 indexed citations
17.
Bai, Yun, Shifeng Kan, Shixin Zhou, et al.. (2015). Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. Cell Discovery. 1(1). 15040–15040. 49 indexed citations
18.
Dong, Zhao‐Ru, Shanji Fu, Xiaofei Xu, et al.. (2014). Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration. British Journal of Cancer. 110(7). 1801–1810. 40 indexed citations
19.
Zheng, Ni, Xia Zhang, Shifeng Kan, et al.. (2011). Up‐regulation of HLA‐G expression in cervical premalignant and malignant lesions. Tissue Antigens. 77(3). 218–224. 45 indexed citations
20.
Yoshimi, Noriko, et al.. (1988). Minute Esophageal Granular Cell Tumor: A Case Report with Immunohistochemical and Ultrastructural Examination. Japanese Journal of Clinical Oncology. 18(3). 275–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongzhong Luo Breakdown of academic impact, for papers by Anna Paczulla Breakdown of academic impact, for papers by Yue Teng Breakdown of academic impact, for papers by Chengcheng Liao Breakdown of academic impact, for papers by Qi Niu Breakdown of academic impact, for papers by Michael Cangkrama Breakdown of academic impact, for papers by Chengyu Lv Breakdown of academic impact, for papers by Xiangyu Zhai Breakdown of academic impact, for papers by Huijuan Zhou
Rankless by CCL
2026